Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Invesco India PSU Equity Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹79.90 |
| 12 Apr 2015 | ₹137.79 |
| 31 May 2016 | ₹132.98 |
| 19 Jul 2017 | ₹191.92 |
| 07 Sep 2018 | ₹181.15 |
| 27 Oct 2019 | ₹195.19 |
| 15 Dec 2020 | ₹212.40 |
| 03 Feb 2022 | ₹293.08 |
| 25 Mar 2023 | ₹323.27 |
| 12 May 2024 | ₹652.88 |
| 01 Jul 2025 | ₹747.31 |
| 20 Aug 2026 | ₹760.96 |
| Metric | Invesco · Direct NAV ₹79.14 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +7.29% | +7.23% | |
| +23.42% | +16.94% | |
| +23.55% | +14.70% | |
| +16.88% | +15.10% | |
| +16.06% | +14.07% | |
| +20.91% | — | |
| +19.27% | +17.59% | |
| +17.23% | +16.29% | |
| +18.25% | +16.00% | |
| Risk | ||
| 22.34% | 15.69% | |
| 0.76 | 0.52 | |
| 1.01 | 0.73 | |
| -33.42% | -23.08% | |
| Nifty 500 | — | |
| +9.85% | +4.66% | |
| 1.30 | 0.96 | |
| 152.8% | 109.1% | |
| 121.9% | 91.0% | |
| 1.25% | 1.14% | |
| ₹1,490Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 23% | 45% | |
| Hiten Jain · 1.1y | — | |
| 02 Jan 2013 | — | |
| 24 | — | |
| 59.4% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.